Doctor | Upstate Patient Care | SUNY ...

Dr. Michael D. Mix

Claim this profile

State University of New York Upstate Medical University

Studies Lung Cancer
Studies Small Cell Lung Cancer
11 reported clinical trials
31 drugs studied

Area of expertise

1Lung Cancer
Michael D. Mix has run 7 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I
2Small Cell Lung Cancer
Michael D. Mix has run 4 trials for Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.
State University Of New York Upstate Medical University
Image of trial facility.
SUNY Upstate Medical University

Clinical Trials Michael D. Mix is currently running

Image of trial facility.

Stereotactic Radiosurgery vs. HA-WBRT + Memantine

for Brain Cancer

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting2 awards Phase 3
Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria

More about Michael D. Mix

Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Michael D. Mix has experience with
  • Carboplatin
  • Paclitaxel
  • Stereotactic Body Radiation Therapy
  • Atezolizumab
  • Pemetrexed
  • HFR Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Michael D. Mix specialize in?
Is Michael D. Mix currently recruiting for clinical trials?
Are there any treatments that Michael D. Mix has studied deeply?
What is the best way to schedule an appointment with Michael D. Mix?
What is the office address of Michael D. Mix?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security